Costs of digital adherence technologies for tuberculosis treatment support
Nsengiyumva, N. P. P.; Khan, A.; Gler, M. M. T. S.; Lopez, M.; Marcelo, D.; Andrews, M. C.; Duverger, K.; Ahmed, S.; Ibrahim, T.; Morales, M. L.; Villanueva, A.; Efo, E.; Onajare, B.; Celan, C.; Schwartzman, K.
Show abstract
Digital adherence technologies (DATs) are increasingly used for tuberculosis (TB) adherence support, but information about their costs remains limited. We used microcosting to estimate health system costs (in 2022 US dollars) of 99DOTS pill sleeves and video-observed treatment (VOT), implemented in demonstration projects during 2018-21. Local cost estimates for standard directly observed treatment (DOT) were also obtained. The estimated per-person costs of 99DOTS for drug-sensitive (DS-) TB were $98, $106, and $174 in Bangladesh (n=719), the Philippines (n=396), and Tanzania (n=976) respectively. The estimated per-person costs of VOT were $1 154, $304, $457, and $661 in Haiti (n=87 DS-TB), Moldova (n=173 DS-TB), Moldova (n=135 drug-resistant [DR]-TB) and the Philippines (n=110 DR-TB) respectively. Health system costs of 99DOTS may be similar to or cheaper than standard DOT. VOT is considerably more expensive; labor cost offsets and/or economies of scale may yield savings relative to standard DOT in some settings. SummaryIn diverse settings, health system costs of 99DOTS pill sleeves may be similar to or cheaper than standard directly observed treatment for TB; video-observed treatment is considerably more expensive, but labor cost offsets and/or economies of scale may yield savings.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluating the health impact, health-system costs and cost-effectiveness of using TrueNat on stool samples compared to usual care for the diagnosis of paediatric tuberculosis in primary care settings: a modelling analysis 95%
- Treatment preferences among people at risk of developing tuberculosis: a discrete choice experiment 95%
- Integrating Isoniazid Preventive Therapy into the Fast-Track HIV Treatment Model in Urban Zambia: A Proof-of -Concept Pilot Project 94%
Similar papers in this journal
- Programmatic diagnostic accuracy and clinical utility of Xpert MTB/XDR in patients with rifampicin-resistant tuberculosis in Georgia 92%
- Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda 92%
- Understanding non-adherence to tuberculosis medications in India using urine drug metabolite testing: a cohort study 92%
Similar papers in this journal
- Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda 95%
- Impact of a pilot mHealth intervention on treatment outcomes of TB patients seeking care in the private sector using Propensity Scores Matching – Evidence collated from New Delhi, India 94%
- Improving outcomes for children with malaria, diarrhoea and pneumonia in Mozambique through the inSCALE technology innovation: A cluster randomised controlled trial 93%
Similar papers in this journal
- Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia 94%
- Implementation outcomes of tuberculosis digital adherence technologies: a scoping review using the RE-AIM framework 93%
- Contextual factors influencing implementation of tuberculosis digital adherence technologies: a scoping review guided by the RE-AIM framework 93%
Similar papers in this journal
- A Yield And Cost Comparison Of TB Contact Investigation And Intensified Case Finding In Uganda 95%
- Outcomes of Isoniazid Preventive Therapy among people living with HIV in Kenya: A retrospective study of routine health care data 93%
- Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.